COMMUNIQUÉS West-GlobeNewswire

Cesca Therapeutics to Announce Financial Results for the First Quarter Ended March 31, 2018 and Host Conference Call on May 14
09/05/2018
RANCHO CORDOVA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca” or the “Company”) (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based [...]
resTORbio Completes Dosing of Patients in Phase 2b Study to Reduce the Incidence of Respiratory Tract Infections in the Elderly
09/05/2018
Topline 16-week data now expected in the third quarter of 2018 BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ: TORC ), a clinical-stage biopharmaceutical company focused on helping people live [...]
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2018 Financial Results
09/05/2018
Company to Hold Conference Call and Webcast at 9:00 a.m. Eastern Time on Tuesday May 15, 2018 NEWTOWN, Pa., May 09, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3-stage biopharmaceutical [...]
Arrayit Corporation Announces New Clinical Licensure from the Centers for Medicare and Medicaid Services
09/05/2018
Sunnyvale, May 09, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces receipt of a new clinical licensure from the Centers for Medicare and Medicaid [...]
First Choice Healthcare Solutions Reports First Quarter 2018 Results and Expansion into New Territory
09/05/2018
MELBOURNE, Fla., May 09, 2018 (GLOBE NEWSWIRE) -- First Choice Healthcare Solutions, Inc. (OTCQB:FCHS) ("First Choice" or the "Company"), a fully integrated, non-physician-owned, publicly traded healthcare delivery [...]
Verona Pharma to Present Clinical Trial Data of RPL554 for COPD Maintenance Treatment at American Thoracic Society 2018 International Conference
09/05/2018
LONDON, May 09, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
PolarityTE™ Accelerates Sales Team for Targeted Regional Release of SkinTE™
09/05/2018
SALT LAKE CITY, May 09, 2018 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (Nasdaq: COOL ) announced today that it is growing its commercial presence by hiring dedicated sales representatives on the East Coast to accelerate the [...]
Tabula Rasa HealthCare Releases Research Results Re: Pharmacist-Led Pharmacogenomics (PGx) Services for PACE
09/05/2018
Study Published in Journal of the American Pharmacists Association MOORESTOWN, N.J., May 09, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ: TRHC ), a healthcare technology company optimizing [...]
Cantabio Pharmaceuticals to Present Positive in vivo Efficacy Data in a Mice Model of Parkinson’s disease from Its DJ-1 Protein Targeting Therapeutic Program at the Neuro4D Conference in Mainz, Germany
09/05/2018
SAN FRANCISCO, May 09, 2018 (GLOBE NEWSWIRE) -- Cantabio Pharmaceuticals Inc. (OTCQB:CTBO), a biopharmaceutical company developing novel disease modifying therapies for Alzheimer's (AD), Parkinson's (PD) and other [...]
Proteon Therapeutics Announces First Quarter 2018 Financial Results
09/05/2018
WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Endocyte Provides First Quarter 2018 Financial Results and Operational Update
09/05/2018
-Recently Updated Phase 2 Data on 177 Lu-PSMA-617 Published in The Lancet Oncology Favorable to Preliminary Data Presented at 2017 ESMO Congress- -Positive End of Phase 2 FDA Meeting Set Stage for Successful Financing [...]
Endocyte Announces The Lancet Oncology Publication of Phase 2 Data From Investigator-Initiated Prostate Cancer Trial of (177)Lu-PSMA-617
09/05/2018
-Publication includes analysis of original 30 patients previously presented at 2017 ESMO by Professor Michael Hofman of Peter MacCallum Cancer Centre- -Relative to previously presented data, publication reflects longer [...]
BioSig Technologies Announces Acceptance of Paper for the 40th International Conference of the IEEE Engineering in Medicine and Biology Society
09/05/2018
Paper regarding unipolar intracardiac signals as a parameter for catheter contact to be presented at EMBC ‘18 July 17-21 in Honolulu, Hawaii Santa Monica, CA, May 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( [...]
Albireo to Host First Quarter 2018 Business Update Conference Call and Webcast on May 17, 2018
09/05/2018
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that management will host a [...]
Bio-Path Holdings to Announce First Quarter 2018 Financial Results on May 16, 2018
09/05/2018
HOUSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Intra-Cellular Therapies to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
09/05/2018
NEW YORK, May 09, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system ("CNS") disorders, today [...]
Krystal Biotech Presents In Vivo KB103 Data at the International Investigative Dermatology Conference that Show Human COL7 Incorporating into Anchoring Fibrils with Proper Structural Orientation
09/05/2018
Lead product candidate, KB103, shown to successfully transfer COL7A1 gene and to correct recessive dystrophic epidermolysis bullosa (RDEB) PITTSBURGH, May 09, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. , (“Krystal [...]
Selecta Biosciences Announces First Quarter 2018 Financial Results and Provides Corporate Update
09/05/2018
3-month Phase 2 data presented at PANLAR 2018 indicate SEL-212 (SVP-Rapamycin + pegsiticase) product profile may provide better and more sustained serum uric acid control, fewer flares, and less frequent dosing compared [...]
CareDx expands NGS Transplant Product Offerings
09/05/2018
License and Commercialization Agreement with Illumina BRISBANE, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- CareDx (NASDAQ: CDNA ), today announced that, as reported in its Current Report on Form 8-K filed with the [...]

Pages